Hematopoietic Adverse Events Associated with BNT162b2 mRNA Covid-19 Vaccine

被引：6

作者：

Erdogdu, Batuhan ^{[1
]}

Cinar, Olgu Erkin ^{[1
]}

Malkan, Umit Yavuz ^{[1
]}

Aksu, Salih ^{[1
]}

Demiroglu, Haluk ^{[1
]}

Buyukasik, Yahya ^{[1
]}

Goker, Hakan ^{[1
]}

Sayinalp, Nilgun ^{[1
]}

Haznedaroglu, Ibrahim Celalettin ^{[1
]}

机构：

[1] Hacettepe Univ, Fac Med, Dept Hematol, Ankara, Turkey

来源：

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI | 2022年 / 32卷 / 01期

关键词：

D O I：

10.4999/uhod.226097

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Our second case is a 49-year-old female patient, two days after receiving BNT162b2 mRNA COVID-19 vaccine, petechiae was started in arms and then in lower extremities. The complaints of weakness and fatigue continued to increase within days. The patient, who was admitted to the hospital ten days later with these complaints, was found to have bi-cytopenia. Bone marrow aspiration and biopsy reported that 20-30% stained with cd19 diffuse positive Terminal deoxynucleotidyl transferase (TdT) in blastic cells. HyperCVAD chemotherapy was started with the diagnosis of b-acute lymphoOur third case is a 57-year-old male patient, difficulty in swallowing, and oral ulceration after vaccination of BNT162b2 mRNA COVID-19 vac

引用

页码：65 / 67

页数：3

共 50 条

[11] BNT162b2 Covid-19 Vaccine in Adolescents
Lin, Chen-Hsing
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (14): : 1342 - 1343
[12] Secondary Syphilis Unmasked by BNT162b2 mRNA COVID-19 Vaccine
Potasman, Israel
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2022, 24 (05): : 337 - 338
[13] Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy
Inoue, Sumito
Igarashi, Akira
Morikane, Keita
Hachiya, Osamu
Watanabe, Masafumi
Kakehata, Seiji
Sato, Shinya
Ueno, Yoshiyuki
RESPIRATORY INVESTIGATION, 2022, 60 (02) : 248 - 255
[14] Adie Pupil After BNT162b2 mRNA COVID-19 Vaccine
Gonultas, Eda Nur
Can, Gamze Dereli
JOURNAL OF NEURO-OPHTHALMOLOGY, 2024, 44 (01) : e141 - e142
[15] Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
Kulsirichawaroj, Pimchanok
Sanmaneechai, Oranee
Wittawatmongkol, Orasri
Chokephaibulkit, Kulkanya
VACCINES, 2022, 10 (01)
[16] Unusual lymphadenopathies secondary to the BNT162b2 mRNA Covid-19 vaccine
Manuel Felices-Farias, Jose
Francisco Martinez-Martinez, Juan
Guzman-Aroca, Florentina
MEDICINA CLINICA, 2022, 158 (07): : 343 - 344
[17] Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents
Mansanguan, Suyanee
Charunwatthana, Prakaykaew
Piyaphanee, Watcharapong
Dechkhajorn, Wilanee
Poolcharoen, Akkapon
Mansanguan, Chayasin
TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2022, 7 (08)
[18] Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Barda, Noam
Dagan, Noa
Ben-Shlomo, Yatir
Kepten, Eldad
Waxman, Jacob
Ohana, Reut
Hernan, Miguel A.
Lipsitch, Marc
Kohane, Isaac
Netzer, Doron
Reis, Ben Y.
Balicer, Ran D.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (12): : 1078 - 1090
[19] Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine
de Montjoye, L.
Marot, L.
Baeck, M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (01) : E26 - E28
[20] Efficacy of the BNT162b2 mRNA COVID-19 vaccine in a haemodialysis cohort
Frantzen, Luc
Cavaille, Guilhem
Thibeaut, Sandrine
El-Haik, Yohan
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36 (09) : 1756 - 1757

← 1 2 3 4 5 →